Paracetamol Drug For Further Processing - NDC Database
Paracetamol Drug For Further Processing
National Drug Code (NDC) records including drug products, labelers, dosage forms, strengths, substances and marketing information.
Advertise Here
Reach qualified buyersBoost your visibility among pharma sourcing professionals and potential buyers.
- Grow your business with qualified leads
- GDS reports on your ad performance
- Targeted to this product's audience
- Direct enquiries from buyers
- Visibility to pharma professionals
NDC Records Timeline (104 records)
NDC
11014-0353
Labeler
Catalent Pharma Solutions, LLC
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE
Strength
325 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-02-17
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
59917-026
Labeler
Adare Pharmaceuticals Inc
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
1 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1984-01-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
57298-050
Labeler
Adare Pharmaceuticals Srl
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
1 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2000-05-01
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
63189-021
Labeler
AMOL PHARMACEUTICALS PRIVATE LIMITED
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
500 mg/.95g
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-03-04
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-006
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen and Diphenhydramine Hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-01-11
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-007
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-01-05
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-008
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
325 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-01-05
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-009
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-03-14
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-014
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-03-14
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-021
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
160 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-09-12
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-023
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
160 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-09-12
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-034
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen and Diphenhydramine Hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-01-08
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-036
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-01-08
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
70120-155
Labeler
APL HEALTHCARE LIMITED
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-10-08
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
53604-701
Labeler
Atabay Kimya Sanayi ve Ticaret Anonim Sirketi
Nonproprietary Name
ACETAMINOPHEN
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
900 mg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-01-01
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
53604-702
Labeler
Atabay Kimya Sanayi ve Ticaret Anonim Sirketi
Nonproprietary Name
ACETAMINOPHEN
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
900 mg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-01-01
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
53604-703
Labeler
Atabay Kimya Sanayi ve Ticaret Anonim Sirketi
Nonproprietary Name
ACETAMINOPHEN
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
900 mg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-01-01
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
69988-0024
Labeler
Catalent Micron Technologies, Inc.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
1 kg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2000-08-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
61474-4398
Labeler
Catalent Ontario Limited
Nonproprietary Name
Acetaminophen, Guaifenesin, Phenylephrine Hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE, LIQUID FILLED
Strength
325; 200; 5 mg/1; mg/1; mg/1
Substance
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-05-12
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
81842-418
Labeler
Coating Place, LLC
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
GRANULE
Strength
100 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1994-06-08
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
10267-3711
Labeler
Contract Pharmacal Corp.
Nonproprietary Name
Acetaminophen, Diphenhydramine Hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
325; 50 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-10-16
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
10267-5923
Labeler
Contract Pharmacal Corp.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-09-21
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
14803-174
Labeler
ELYSIUM PHARMACEUTICALS LIMITED
Nonproprietary Name
Acetaminophen, Diphenhydramine Hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-12-11
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
81919-101
Labeler
HEBEI JIHENG PHARMACEUTICAL CO., LTD.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
GRANULE
Strength
1 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-11-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
81919-102
Labeler
Hebei Jiheng Pharmaceutical Co., Ltd.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
GRANULE
Strength
1 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-09-21
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
81919-103
Labeler
Hebei Jiheng Pharmaceutical Co., Ltd.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
GRANULE
Strength
1 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-01-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62579-401
Labeler
Janssen Cilag SpA
Nonproprietary Name
Acetaminophen, Guaifenesin, and Phenylephrine hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
325; 200; 5 mg/1; mg/1; mg/1
Substance
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-04-07
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62579-680
Labeler
Janssen Cilag SpA
Nonproprietary Name
Acetaminophen, Guaifenesin, and Phenylephrine hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
325; 200; 5 mg/1; mg/1; mg/1
Substance
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-10
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
50580-248
Labeler
Kenvue Brands LLC
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-03-06
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
50580-589
Labeler
Kenvue Brands LLC
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-05-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
65498-108
Labeler
Kenvue Canada Inc.
Nonproprietary Name
Paracetamol
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500 mg/500mg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-05-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
65498-475
Labeler
Kenvue Canada Inc.
Nonproprietary Name
Paracetamol
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
325 mg/325mg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-04-30
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0113-4004
Labeler
L. Perrigo Company
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
650 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2000-05-12
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0113-4010
Labeler
L. Perrigo Company
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
650 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-08-03
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0113-4013
Labeler
L. Perrigo Company
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
650 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-03-26
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
10888-8171
Labeler
Patheon Softgels Inc.
Nonproprietary Name
ACETAMINOPHEN
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-05-28
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
10888-8174
Labeler
Patheon Softgels Inc.
Nonproprietary Name
acetaminophen and diphenhydramine hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-05-28
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
10888-8175
Labeler
Patheon Softgels Inc.
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, EXTENDED RELEASE
Strength
650 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-11-14
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
10888-8176
Labeler
Patheon Softgels Inc.
Nonproprietary Name
acetaminophen and diphenhydramine hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-09-28
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
10888-8249
Labeler
Patheon Softgels Inc.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE, LIQUID FILLED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-17
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
10888-8274
Labeler
Patheon Softgels Inc.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE, LIQUID FILLED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-10-15
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
68094-075
Labeler
Precision Dose, Inc.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
SUSPENSION
Strength
160 mg/5mL
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-04-01
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
68210-0008
Labeler
Prodose, Inc.
Nonproprietary Name
ACETAMINOPHEN and DIPHENHYDRAMINE HYDROCHLORIDE
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-01-05
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
68210-1014
Labeler
Prodose, Inc.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-02-10
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
68210-4203
Labeler
Prodose, Inc.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
325 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-07-19
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
68210-5047
Labeler
Prodose, Inc.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE, LIQUID FILLED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-06-12
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
68210-5055
Labeler
Prodose, Inc.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE, LIQUID FILLED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-17
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
63824-794
Labeler
RB Health (US) LLC
Nonproprietary Name
Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
325; 200; 5 mg/1; mg/1; mg/1
Substance
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-06-15
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
83059-0015
Labeler
Shield Pharmaceuticals Corp
Nonproprietary Name
Acetaminophen 325 mg, Phenylephrine HCl 5 mg, Guaifenesin 200 mg
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
325; 200; 5 mg/1; mg/1; mg/1
Substance
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-02-29
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
83059-0039
Labeler
Shield Pharmaceuticals Corp
Nonproprietary Name
Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
325; 200; 5 mg/1; mg/1; mg/1
Substance
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-07-03
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
83059-0079
Labeler
Shield Pharmaceuticals Corp
Nonproprietary Name
ACETAMINOPHEN
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE, LIQUID FILLED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-02-12
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
83059-0087
Labeler
Shield Pharmaceuticals Corp
Nonproprietary Name
Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
325; 200; 5 mg/1; mg/1; mg/1
Substance
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-04-12
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
83059-0102
Labeler
Shield Pharmaceuticals Corp
Nonproprietary Name
ACETAMINOPHEN
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-11-06
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
83059-0159
Labeler
Shield Pharmaceuticals Corp
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
325 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-06-10
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
83059-0161
Labeler
Shield Pharmaceuticals Corp
Nonproprietary Name
ACETAMINOPHEN
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-11-06
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
58103-115
Labeler
SPI Pharma, Inc.
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
92 kg/100kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-05
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62485-014
Labeler
TCB USA Corporation
Nonproprietary Name
Acetaminophen and Diphenhydramine HCL
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-24
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62485-029
Labeler
TCB USA Corporation
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-11-17
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62485-033
Labeler
TCB USA Corporation
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
325 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-03-02
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62485-034
Labeler
TCB USA Corporation
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-04-05
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62485-035
Labeler
TCB USA Corporation
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-04-05
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62485-044
Labeler
TCB USA Corporation
Nonproprietary Name
Acetaminophen and Diphenhydramine HCL
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-24
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62485-045
Labeler
TCB USA Corporation
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-11-17
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
55132-014
Labeler
TRUECARE BIOMEDIX
Nonproprietary Name
Acetaminophen and Diphenhydramine HCL
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
55132-019
Labeler
TRUECARE BIOMEDIX
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-04-26
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
51114-0218
Labeler
Vovantis Laboratories Private Limited
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, EFFERVESCENT
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-02-09
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
51114-0219
Labeler
Vovantis Laboratories Private Limited
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, EFFERVESCENT
Strength
160 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-02-09
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
51114-0221
Labeler
Vovantis Laboratories Private Limited
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, EFFERVESCENT
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-02-09
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
16528-002
Labeler
Zibo Xinhua - Perrigo Pharmaceutical Co., Ltd
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-04-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
16528-210
Labeler
Zibo Xinhua - Perrigo Pharmaceutical Co., Ltd
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-09-29
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
57631-004
Labeler
InvaTech Pharma Solutions LLC
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-09-26
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
59651-034
Labeler
Aurobindo Pharma Limited
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET, EXTENDED RELEASE
Strength
650 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-11-09
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
84386-060
Labeler
Aurobindo Pharma Limited
Nonproprietary Name
Auropap 90F (Acetaminophen Directly Compressible Granules)
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
GRANULE
Strength
50 kg/50kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-08-02
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-023
Labeler
Granules India Limited
Nonproprietary Name
Panadol Optizorb Granulate
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
GRANULE
Strength
603 mg/10001
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-09-04
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-040
Labeler
Granules India Limited
Nonproprietary Name
acetaminophen extra strength red
Marketing Category
EXPORT ONLY
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-044
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen
Marketing Category
EXPORT ONLY
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-050
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen Extra Strength
Marketing Category
EXPORT ONLY
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-078
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen
Marketing Category
EXPORT ONLY
Dosage Form
TABLET
Strength
500 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-02
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
62207-100
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen Directly compressible granules 90%
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
90 mg/100mg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-10-22
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-101
Labeler
Granules India Limited
Nonproprietary Name
Compresso PAP 90 CPF
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
90 mg/100mg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-08-16
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-167
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE, GELATIN COATED
Strength
499.5 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-10-29
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-200
Labeler
Granules India Limited
Nonproprietary Name
Compresso PAP 90 CPC
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
90 mg/100mg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-11-05
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
62207-202
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen Directly compressible granules 90%
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
90 mg/100mg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-05-12
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-204
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen Directly compressible granules 90%
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
89.605 mg/89.605mg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-10-04
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-234
Labeler
Granules India Limited
Nonproprietary Name
acetaminophen
Marketing Category
EXPORT ONLY
Dosage Form
TABLET, EXTENDED RELEASE
Strength
650 mg/1
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-01-01
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-600
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen 80% and Diphenhydramine Hcl 4% Directly compressible granules
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
80; 4 mg/100mg; mg/100mg
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-02-10
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-661
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen and Diphenhydramine Hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
TABLET
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-12-05
End Marketing Date
-
Listing / Certification
2027-12-31
NDC
62207-664
Labeler
Granules India Limited
Nonproprietary Name
Acetaminophen and Diphenhydramine Hydrochloride
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
CAPSULE
Strength
500; 25 mg/1; mg/1
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-01-14
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-702
Labeler
Granules India Limited
Nonproprietary Name
Compresso PAP 90CPF
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
90 mg/100mg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-04-11
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
62207-930
Labeler
Granules India Limited
Nonproprietary Name
Paracetamol
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
1 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-06-12
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-0090
Labeler
SpecGx LLC
Nonproprietary Name
Acetaminophen Anhydrous Basis
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.9 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1982-12-20
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-0093
Labeler
SpecGx LLC
Nonproprietary Name
Acetaminophen Anhydrous Basis
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.9 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1982-12-20
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-0114
Labeler
SpecGx LLC
Nonproprietary Name
ACETAMINOPHEN ANHYDROUS BASIS
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.9 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-08
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-0161
Labeler
SpecGx LLC
Nonproprietary Name
Acetaminophen Anhydrous Basis
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.9 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1982-12-20
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-0244
Labeler
SpecGx LLC
Nonproprietary Name
Acetaminophen Anhydrous Basis
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.9 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-11
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-0960
Labeler
SpecGx LLC
Nonproprietary Name
Acetaminophen Anhydrous Basis
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.9 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1982-12-20
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-2907
Labeler
SpecGx LLC
Nonproprietary Name
acetaminophen anhydrous basis
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.95 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-13
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-3930
Labeler
SpecGx LLC
Nonproprietary Name
Acetaminophen Anhydrous Basis / Paracetamol Ph Eur
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.97 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-11
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-3973
Labeler
SpecGx LLC
Nonproprietary Name
PARACETAMOL
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.96 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-08
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-3975
Labeler
SpecGx LLC
Nonproprietary Name
PARACETAMOL
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.96 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-08
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-4255
Labeler
SpecGx LLC
Nonproprietary Name
acetaminophen
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.95 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-13
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-4377
Labeler
SpecGx LLC
Nonproprietary Name
PARACETAMOL
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.955 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-08
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-6114
Labeler
SpecGx LLC
Nonproprietary Name
ACETAMINOPHEN ANHYDROUS BASIS
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.9 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-08
End Marketing Date
-
Listing / Certification
2026-12-31
NDC
0406-7509
Labeler
SpecGx LLC
Nonproprietary Name
ACETAMINOPHEN ANHYDROUS BASIS
Marketing Category
DRUG FOR FURTHER PROCESSING
Dosage Form
POWDER
Strength
0.9 kg/kg
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
1997-09-09
End Marketing Date
-
Listing / Certification
2026-12-31
Advertise on PharmaJungle - Free for 30 Days
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
- 30 days of free advertising
- Visibility across all pages
- Performance report with ad insights
- No setup or registration fee
Exclusive introductory offer for new advertisers
Related Databases
5 of 6 have recordsProduct Type Breakdown
104 total- DRUG FOR FURTHER PROCESSING
Official Source
NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).
Visit FDA NDC DirectoryRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Substance
ACETAMINOPHEN
Identifiers
NDC: 11014-0353
DEA Schedule:
Official FDA Data
Based on publicly available FDA NDC information
National Drug Code
Structured NDC product information
Product Information
Drug, labeler and marketing data
Easy to Explore
Search and filter NDC records
Filter NDC records
Options with no matching records are greyed out.
Post your requirement
Get offers from suppliers
- Reach pharmaceutical suppliers
- Specify quality standard and quantity
- Set your shipping preference
- Receive offers directly
- Listed on our marketplace
Your product details and requirements may be published on the marketplace.
Create a New Buying Request
Fields marked with * are mandatory.